Added aid to curb virus: Molnupiravir is able to reduce 50% of hospital admissions and is effective against more infectious variants of Covid-19 including Gamma, Delta and Mu, says a research. — Reuters
PETALING JAYA: The antiviral drug Molnupiravir will not replace vaccines but will offer an alternative in treating Covid-19 patients, health experts have pointed out.
Universiti Malaya epidemiologist Prof Datuk Dr Awang Bulgiba Awang Mahmud said the drug could reduce transmission in patients.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
